DrugPatentWatch Database Preview
Drugs in Development Information for Voclosporin
» See Plans and Pricing
What is the drug development status for Voclosporin?
Voclosporin is an investigational drug.
There have been 17 clinical trials for Voclosporin.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2011.
The most common disease conditions in clinical trials are Nephritis, Lupus Nephritis, and Keratoconjunctivitis Sicca. The leading clinical trial sponsors are Aurinia Pharmaceuticals Inc., Lux Biosciences, Inc., and Leiden University Medical Center.
Summary for Voclosporin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 7 |
| WIPO Patent Applications | 534 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2011-02-01) |
| Vendors | 10 |
Recent Clinical Trials for Voclosporin
| Title | Sponsor | Phase |
|---|---|---|
| Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients | Aurinia Pharmaceuticals Inc. | Phase 2 |
| Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients | Leiden University Medical Center | Phase 2 |
| Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrome | Aurinia Pharmaceuticals Inc. | Phase 2/Phase 3 |
Clinical Trial Summary for Voclosporin
Top disease conditions for Voclosporin
Top clinical trial sponsors for Voclosporin
US Patents for Voclosporin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
